KalVista Pharmaceuticals Inc Sustainability Reports
KalVista Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors. The company specializes in oral treatments for rare conditions such as hereditary angioedema.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900Q7IDA3WUGRZA51
FIGI: BBG0026ZG5C9
4 reports from 2018 to 2024
